BB
GILD icon

Busey Bank’s Gilead Sciences GILD Stock Holding History

Busey Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$345K Sell
2,477
-2,584
-51% -$362K 0.01% 282
2025
Q4 		$621K Buy
5,061
+116
+2% +$14.1K 0.02% 225
2025
Q3 		$549K Buy
4,945
+18
+0.4% +$2.05K 0.02% 235
2025
Q2 		$546K Buy
4,927
+32
+0.7% +$3.41K 0.02% 229
2025
Q1 		$548K Sell
4,895
-292
-6% -$30.1K 0.02% 228
2024
Q4 		$479K Buy
5,187
+26
+0.5% +$2.34K 0.02% 235
2024
Q3 		$433K Sell
5,161
-809
-14% -$61.7K 0.01% 251
2024
Q2 		$410K Sell
5,970
-764
-11% -$51K 0.01% 254
2024
Q1 		$493K Buy
6,734
+729
+12% +$56.1K 0.02% 245
2023
Q4 		$486K Sell
6,005
-1,476
-20% -$115K 0.02% 234
2023
Q3 		$561K Buy
7,481
+37
+0.5% +$2.85K 0.02% 211
2023
Q2 		$574K Sell
7,444
-770
-9% -$61.4K 0.02% 217
2023
Q1 		$682K Buy
8,214
+1,457
+22% +$121K 0.03% 204
2022
Q4 		$580K Sell
6,757
-37
-0.5% -$2.93K 0.03% 216
2022
Q3 		$419K Sell
6,794
-12
-0.2% -$757 0.02% 239
2022
Q2 		$420K Sell
6,806
-403
-6% -$25K 0.02% 247
2022
Q1 		$429K Sell
7,209
-1,533
-18% -$98K 0.02% 262
2021
Q4 		$635K Buy
8,742
+1
+0% +$69 0.02% 232
2021
Q3 		$610K Buy
+8,741
New +$614K 0.02% 231
2020
Q3 		– Sell
-3,388
Closed -$260K – 327
2020
Q2 		$260K Buy
3,388
+203
+6% +$15.6K 0.02% 270
2020
Q1 		$238K Sell
3,185
-38,117
-92% -$2.63M 0.02% 273
2019
Q4 		$2.68M Buy
41,302
+591
+1% +$38.5K 0.18% 115
2019
Q3 		$2.58M Buy
40,711
+7,944
+24% +$519K 0.19% 114
2019
Q2 		$2.21M Sell
32,767
-217
-0.7% -$14.3K 0.21% 92
2019
Q1 		$2.14M Sell
32,984
-31,664
-49% -$2.1M 0.19% 93
2018
Q4 		$4.04M Sell
64,648
-23,148
-26% -$1.62M 0.42% 67
2018
Q3 		$6.78M Buy
87,796
+1,040
+1% +$78.5K 0.63% 50
2018
Q2 		$6.15M Buy
86,756
+5,817
+7% +$411K 0.61% 52
2018
Q1 		$6.1M Buy
80,939
+28,959
+56% +$2.3M 0.64% 50
2017
Q4 		$3.72M Sell
51,980
-18,456
-26% -$1.4M 0.48% 63
2017
Q3 		$5.71M Sell
70,436
-620
-0.9% -$47.4K 0.68% 51
2017
Q2 		$5.03M Buy
71,056
+3,097
+5% +$206K 0.69% 49
2017
Q1 		$4.62M Buy
67,959
+11,715
+21% +$824K 0.56% 61
2016
Q4 		$4.03M Sell
56,244
-7,530
-12% -$560K 0.51% 63
2016
Q3 		$5.05M Sell
63,774
-18,163
-22% -$1.48M 0.66% 54
2016
Q2 		$6.83M Buy
81,937
+3,007
+4% +$267K 0.88% 40
2016
Q1 		$7.25M Buy
78,930
+7,035
+10% +$634K 0.96% 38
2015
Q4 		$7.28M Buy
71,895
+3,862
+6% +$402K 0.97% 38
2015
Q3 		$6.68M Buy
68,033
+3,474
+5% +$386K 0.95% 36
2015
Q2 		$7.56M Buy
64,559
+3,447
+6% +$377K 1.02% 36
2015
Q1 		$6M Buy
61,112
+18,612
+44% +$1.89M 0.81% 44
2014
Q4 		$4.01M Buy
42,500
+641
+2% +$66.3K 0.55% 63
2014
Q3 		$4.46M Buy
+41,859
New +$4.1M 0.65% 53

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Busey Bank's GILD Position: Q1 2026 in Review

Busey Bank reduced its Gilead Sciences (GILD) stake by 51% in Q1 2026, selling an estimated $362K and leaving 2,477 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #282.

Busey Bank first reported a position in GILD in Q3 2014 and has held it in 43 quarters since. The position peaked at $7.56M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Busey Bank held 2,477 shares of Gilead Sciences worth $345K as of Q1 2026.
  • Busey Bank sold 2,584 Gilead Sciences shares in Q1 2026, an estimated $362K.
  • Gilead Sciences made up 0.01% of Busey Bank's portfolio in Q1 2026, its #282 holding.
  • Busey Bank first reported a position in Gilead Sciences in Q3 2014 and has held it in 43 quarters since.
  • Busey Bank's Gilead Sciences position peaked at $7.56M in Q2 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Busey Bank's 13F filing for Q1 2026, filed 28 Apr 2026.